ATE378054T1 - Mittel zu linderung von hyperglykämie nach dem essen - Google Patents

Mittel zu linderung von hyperglykämie nach dem essen

Info

Publication number
ATE378054T1
ATE378054T1 AT02749378T AT02749378T ATE378054T1 AT E378054 T1 ATE378054 T1 AT E378054T1 AT 02749378 T AT02749378 T AT 02749378T AT 02749378 T AT02749378 T AT 02749378T AT E378054 T1 ATE378054 T1 AT E378054T1
Authority
AT
Austria
Prior art keywords
remedy
eating
levels reduced
cholesterol
hyperglycemia
Prior art date
Application number
AT02749378T
Other languages
English (en)
Inventor
Kenzo Oba
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE378054T1 publication Critical patent/ATE378054T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02749378T 2001-07-30 2002-07-29 Mittel zu linderung von hyperglykämie nach dem essen ATE378054T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001229087 2001-07-30

Publications (1)

Publication Number Publication Date
ATE378054T1 true ATE378054T1 (de) 2007-11-15

Family

ID=19061486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749378T ATE378054T1 (de) 2001-07-30 2002-07-29 Mittel zu linderung von hyperglykämie nach dem essen

Country Status (11)

Country Link
US (1) US7879869B2 (de)
EP (1) EP1413309B1 (de)
JP (1) JP4353414B2 (de)
KR (1) KR100924478B1 (de)
CN (1) CN1270724C (de)
AT (1) ATE378054T1 (de)
CA (1) CA2454732C (de)
DE (1) DE60223551T2 (de)
ES (1) ES2295369T3 (de)
TW (1) TWI324519B (de)
WO (1) WO2003011308A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
WO2005092349A1 (ja) * 2004-03-26 2005-10-06 Mitsubishi Pharma Corporation インスリン抵抗性改善剤
EP1810689A4 (de) * 2004-10-15 2009-07-22 Mitsubishi Tanabe Pharma Corp Mittel zur prävention und/oder behandlung von diabetes
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
US20090162311A1 (en) * 2006-06-16 2009-06-25 Masahiko Yamamori Agent for Prevention and/or Treatment of Glomerulopathy
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US8524212B2 (en) 2007-10-24 2013-09-03 Mitsubishi Tanabe Pharma Corporation Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
CN106478948B (zh) * 2010-02-24 2019-05-07 瑞立普萨公司 用作胆汁酸螯合剂的聚咪唑
JP2014129284A (ja) * 2012-12-28 2014-07-10 Nof Corp 食後血糖上昇抑制剤
CN106366311B (zh) * 2015-07-23 2019-08-13 山东诚创医药技术开发有限公司 一种考来替兰的制备方法
CN106720731A (zh) * 2016-11-30 2017-05-31 广西百利乐生物科技有限公司 高透光率的果汁凉茶的浓缩提取液及其加工工艺
CN106359772A (zh) * 2016-11-30 2017-02-01 广西百利乐生物科技有限公司 防止沉淀的果汁凉茶的浓缩提取液及其加工方法
KR101969719B1 (ko) 2017-07-04 2019-04-17 한남대학교 산학협력단 리시닐-프럭토오즈(Lysinyl-Fructose, LF)를 포함하는 혈당상승 억제제 및 그 제조방법
KR102043461B1 (ko) 2017-12-21 2019-11-11 주식회사 프로테인웍스 아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물
KR20230057134A (ko) 2021-10-21 2023-04-28 한가람비앤에프 주식회사 해죽순 추출물을 포함하는 식후 혈당상승억제용 조성물
KR102450000B1 (ko) 2022-02-20 2022-09-30 이용호 커피 추출물을 포함하는 식후 혈당상승억제용 조성물
KR20230174959A (ko) 2022-06-22 2023-12-29 농업회사법인 그린생명주식회사 아마도리 화합물을 고농도로 함유하는 홍삼 추출물을 포함하는 식후 혈당상승억제용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60209523A (ja) * 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
DE69633502T2 (de) 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
US5847008A (en) * 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
ES2162658T3 (es) 1996-03-05 2002-01-01 Mitsubishi Chem Corp Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia.
US6011049A (en) 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
DK0974356T3 (da) * 1998-07-15 2003-10-27 Merck Sante Sas Tabletter omfattende en kombination af metformin og glibenclamid
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
BR0112800A (pt) * 2000-07-28 2003-07-01 Hoffmann La Roche Utilização de um inibidor de lìpases e de um sequestrante de ácido de bìlis farmaceuticamente aceitáveis e processo para a prevenção e tratamento de enfermidades associadas com altos nìveis de colesterol de plasma
US8173114B2 (en) * 2000-11-28 2012-05-08 Mitsubishi Tanabe Pharma Corporation Excretion accelerator for accumulative chlorine compound

Also Published As

Publication number Publication date
EP1413309A4 (de) 2006-06-07
JP4353414B2 (ja) 2009-10-28
ES2295369T3 (es) 2008-04-16
JPWO2003011308A1 (ja) 2004-11-18
CA2454732C (en) 2010-07-20
CN1270724C (zh) 2006-08-23
US7879869B2 (en) 2011-02-01
DE60223551D1 (de) 2007-12-27
WO2003011308A1 (en) 2003-02-13
EP1413309A1 (de) 2004-04-28
TWI324519B (en) 2010-05-11
KR100924478B1 (ko) 2009-11-03
CN1537010A (zh) 2004-10-13
EP1413309B1 (de) 2007-11-14
CA2454732A1 (en) 2003-02-13
KR20040030858A (ko) 2004-04-09
US20040191209A1 (en) 2004-09-30
DE60223551T2 (de) 2008-10-23

Similar Documents

Publication Publication Date Title
DE60223551D1 (de) Mittel zu linderung von hyperglykämie nach dem essen
WO2001000223A3 (en) Multiple agent diabetes therapy
UY26425A1 (es) Formulación y método antidiabético
JP2004155791A (ja) 新規ｎｉｄｄｍ療法
BR9813961A (pt) Metodo para remover sais biliares de um paciente, polimero de polidialilamina e seus sais, e seu uso.
BRPI0207700B8 (pt) mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
BR0115166A (pt) Combinações de drogas (por exemplo, cloropromazina e pentamidina) para o tratamento de distúrbios neoplásticos
DE50110262D1 (de) Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen
Greenway et al. Double‐blind, randomized, placebo‐controlled clinical trials with non‐prescription medications for the treatment of obesity
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
EP1393738A4 (de) Arzneimittel gegen diabetes
Lee et al. Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice.
Lettieri et al. Effects of beano on the tolerability and pharmacodynamics of acarbose
Cerasi et al. Effect Of Two Sulphonylureas On The Dose Kinetics Of Glucose–Induced Insulin Release In Normal And Diabetic Subjects
NO985676L (no) Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blan
BR9712964A (pt) Embalagem para concordância e método para melhorar ou ajudar a concordância do paciente para dietas com remédio complexo.
Kaur et al. Toxic effects of subacute oral exposure of imidacloprid on biochemical parameters in crossbred cow calves
NO985807L (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
EP1447090B8 (de) Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
BR0308396A (pt) Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
BR0009704A (pt) Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
Rubin et al. Reversible akinetic mutism possibly induced by baclofen
AU2003285426A1 (en) Use of tenatoprazole for the treatment of gastroesophageal reflux

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties